| 000 | 01836 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514052142.0 | ||
| 264 | 0 | _c20030131 | |
| 008 | 200301s 0 0 eng d | ||
| 022 | _a0269-9370 | ||
| 024 | 7 |
_a10.1097/00002030-200211220-00009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHuisman, Maarten T | |
| 245 | 0 | 0 |
_aMultidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs. _h[electronic resource] |
| 260 |
_bAIDS (London, England) _cNov 2002 |
||
| 300 |
_a2295-301 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily G, Member 2 |
| 650 | 0 | 4 |
_aATP-Binding Cassette Transporters _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiological Transport |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aDrug Resistance, Multiple |
| 650 | 0 | 4 |
_aEpithelial Cells _xmetabolism |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xpharmacokinetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndinavir _xpharmacokinetics |
| 650 | 0 | 4 | _aMembrane Transport Proteins |
| 650 | 0 | 4 | _aMultidrug Resistance-Associated Protein 2 |
| 650 | 0 | 4 |
_aMultidrug Resistance-Associated Proteins _xpharmacology |
| 650 | 0 | 4 | _aNeoplasm Proteins |
| 650 | 0 | 4 |
_aRitonavir _xpharmacokinetics |
| 650 | 0 | 4 |
_aSaquinavir _xpharmacokinetics |
| 650 | 0 | 4 | _aTransduction, Genetic |
| 700 | 1 | _aSmit, Johan W | |
| 700 | 1 | _aCrommentuyn, Kristel M L | |
| 700 | 1 | _aZelcer, Noam | |
| 700 | 1 | _aWiltshire, Hugh R | |
| 700 | 1 | _aBeijnen, Jos H | |
| 700 | 1 | _aSchinkel, Alfred H | |
| 773 | 0 |
_tAIDS (London, England) _gvol. 16 _gno. 17 _gp. 2295-301 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002030-200211220-00009 _zAvailable from publisher's website |
| 999 |
_c12248430 _d12248430 |
||